Topics

Groundbreaking HIV vaccine design strategy shows promise in proof-of-principle tests

19:00 EST 6 Nov 2019 | AAAS

(Scripps Research Institute) The new vaccine strategy centers on stimulating the immune system to produce broadly neutralizing antibodies (bnAbs) against HIV. These special antibodies are capable of neutralizing many different strains of the fast-mutating virus by binding to important yet difficult-to-access regions of the virus surface that don't vary much from strain to strain.

Original Article: Groundbreaking HIV vaccine design strategy shows promise in proof-of-principle tests

NEXT ARTICLE

More From BioPortfolio on "Groundbreaking HIV vaccine design strategy shows promise in proof-of-principle tests"

Quick Search

Relevant Topics

Vaccines
A vaccine is any preparation intended to produce immunity to a disease by stimulating the production of antibodies. It creates immunity but does not cause the disease. There are several differnt types of vaccine avalable; Killed microorganisms; which s...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...